Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117
August 28 2013 - 9:00AM
Business Wire
Rexahn Retains its Rights to Cancer
Treatment Compound RX-3117
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024